Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05755893

Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53

Conditions: Endometrial Cancer

Sex: Female
Ages: 20 Years – 80 Years
Enrollment: 100
Sponsor: Assiut University

Summary

The goal of this observational study is to clarify the significance of TB, PDC, DR, MELF, and immunohistochemical expression of those infiltrative patterns in patients with endometrial carcinomas (EC). The main questions it aims to answer are:What is the relationship between TB, PDC, DR, MELF, and other clinicopathological features of patients with endometrial carcinomas (EC)?What is the association of TB, PDC, DR, and MELF patterns with disease-free survival and overall survival?Will the evaluation of the immunohistochemical expression of P53 in the TB, PDC, DR, and MELF patterns be important?

Eligibility Criteria

Inclusion Criteria:Histologically proven Endometrial cancer specimens.underwent total abdominal hysterectomy, with myometrial invasion.Exclusion Criteria:Endometrial biopsieshysterectomy specimens diagnosed with different pathological lesions rather than EC.Specimens with prior chemotherapy or radiotherapy.specimens without myometrial invasion.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05755893). StuddyBuddy aggregates publicly available trial information.